Sage Therapeutics, Inc. (SAGE)
NASDAQ: SAGE · Real-Time Price · USD
5.17
+0.32 (6.60%)
At close: Nov 22, 2024, 4:00 PM
5.10
-0.07 (-1.35%)
After-hours: Nov 22, 2024, 7:45 PM EST

Sage Therapeutics Revenue

Sage Therapeutics had revenue of $11.87M in the quarter ending September 30, 2024, with 337.08% growth. This brings the company's revenue in the last twelve months to $106.40M, up 837.60% year-over-year. In the year 2023, Sage Therapeutics had annual revenue of $86.46M with 1,024.84% growth.

Revenue (ttm)
$106.40M
Revenue Growth
+837.60%
P/S Ratio
2.94
Revenue / Employee
$218,478
Employees
487
Market Cap
316.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202386.46M78.77M1,024.84%
Dec 31, 20227.69M1.38M21.85%
Dec 31, 20216.31M-1.11B-99.43%
Dec 31, 20201.11B1.11B16,123.06%
Dec 31, 20196.87M-83.41M-92.39%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Voyager Therapeutics 163.78M
Spok Holdings 137.71M
iTeos Therapeutics 35.00M
ClearPoint Neuro 30.43M
Delcath Systems 22.64M
Silence Therapeutics 21.77M
Nyxoah 5.67M
Lexicon Pharmaceuticals 5.23M
Revenue Rankings